Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients

BACKGROUND: Ferumoxytol was first approved for clinical use in 2009 solely based on data from trial comparisons with oral iron on biochemical anemia efficacy end points. To compare the rates of important patient outcomes (infection, cardiovascular events and death) between facilities predominantly u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Airy, Medha, Mandayam, Sreedhar, Mitani, Aya A., Chang, Tara I., Ding, Victoria Y., Brookhart, M. Alan, Goldstein, Benjamin A., Winkelmayer, Wolfgang C.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829057/
https://ncbi.nlm.nih.gov/pubmed/26311216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv305
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados